EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 4.0

Reimagining Bioequivalence for the Era of Complex Drug Products: A Quantitative Framework for Generic Drug Development

Allison Dunn, Sooyoung Lee iD, Jogarao V S Gobburu

Clinical and Translational Science · 2026-07 · 19 (7)

DOI: 10.1111/cts.70669 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Clinical and Translational Science, online erschienen am 14.07.2026. Verfasst von Allison Dunn und 2 weiteren Autor:innen. Beteiligte Einrichtung: Center for Translational Medicine, University of Maryland School of Pharmacy, Baltimore, Maryland, USA. Die Arbeit nennt 6 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

Stichwörter der Autor:innen

MIBEMIEbioequivalencecomplex genericsmodelingsimulation

Autor:innen und Institutionen

  • Center for Translational Medicine, University of Maryland School of Pharmacy, Baltimore, Maryland, USA.

ORCID-Profile: Sooyoung Lee

Zitieren

APA

Dunn, A., Lee, S., & Gobburu, J. V. S. (2026). Reimagining Bioequivalence for the Era of Complex Drug Products: A Quantitative Framework for Generic Drug Development. Clinical and Translational Science, 19(7). https://doi.org/10.1111/cts.70669

Vancouver

Dunn A, Lee S, Gobburu JVS. Reimagining Bioequivalence for the Era of Complex Drug Products: A Quantitative Framework for Generic Drug Development. Clinical and Translational Science. 2026;19(7). doi:10.1111/cts.70669

BibTeX
@article{Dunn2026,
  author = {Dunn, Allison and Lee, Sooyoung and Gobburu, Jogarao V S},
  title = {Reimagining Bioequivalence for the Era of Complex Drug Products: A Quantitative Framework for Generic Drug Development},
  journal = {Clinical and Translational Science},
  year = {2026},
  volume = {19},
  number = {7},
  doi = {10.1111/cts.70669}
}
Kostenlos starten →